BusinessAvid Bioservices to Exhibit at 2017 BioProcess International Conference & ExhibitionBy Nasdaq OMXSep 19, 2017, 12:05 PM UTC
BusinessStrategic Global Investments Inc. Announces the Addition of Dr. Monique Barbour to the Board of DirectorsBy Nasdaq OMXSep 13, 2017, 3:59 PM UTC
BusinessPeregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred StockBy Nasdaq OMXSep 5, 2017, 8:05 PM UTC
BusinessIstation CMO Ossa Fisher Accepted into Forbes Communications CouncilBy Nasdaq OMXAug 28, 2017, 12:12 PM UTC
BusinessAvid Bioservices to Exhibit at The Bioprocessing Summit 2017By Nasdaq OMXAug 16, 2017, 12:05 PM UTC
BusinessPeregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent DevelopmentsBy Nasdaq OMXJul 14, 2017, 8:13 PM UTC
BusinessPeregrine to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2017 After Market Close on July 14, 2017By Nasdaq OMXJul 7, 2017, 8:05 PM UTC
BusinessWarburg Pincus Advisor Tom Schodorf Joins Proof: “Unproven Marketing Impact Is a Tax on Growth, Profitability and Shareholder Value”By Nasdaq OMXMay 17, 2017, 2:01 PM UTC
